Mizuho Securities Upgrades Hess Corp. (HES) to Buy
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
- J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Mizuho Securities analyst Paul Sankey upgraded Hess Corp. (NYSE: HES) from Neutral to Buy with a price target of $94.00.
The analyst comments "We believe sustaining capital requirements, excluding exploration and non-producing project spending, are lower for E&Ps with an offshore presence than capital budgets imply. This means higher sustaining free cash flow yield and likely higher capacity for cash return as projects come online and balance sheets normalize. We are upgrading our rating on HES, the most significant beneficiary from this analysis considering the 9BBoe+ resource opportunity at Stabroek, to Buy from Neutral. We believe that start-up at Liza-2 next year and leverage dropping to sub-2.0x pave the way for cash return growth and re-rating of shares closer to NAV value. Other offshore operators (APA and MUR in our coverage) should also benefit, but not as significantly as HES."
Shares of Hess Corp. closed at $71.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Upgrades United Continental (UAL) to Buy Citing Favorable View on Capacity Limit Plans
- Babcock International Group Plc (BAB:LN) (BCKIF) PT Raised to GBP2.60 at Morgan Stanley
- Movida Participacoes SA (MOVI3:BZ) PT Lowered to R$20 at Morgan Stanley
Create E-mail Alert Related CategoriesAnalyst Comments, Hot Comments, Hot Upgrades, Upgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!